Back to search

Article

Alhydrogel TM , a widely used adjuvant, modulates multiple networks implicated in brain aging and has potential in the prevention of age-related cognitive decline

2026-05-25

Abstract excerpt

<title>Abstract</title> <p> <bold>BACKGROUND:</bold> A preliminary efficacy trial in early Alzheimer’s Disease (AD) serendipitously revealed that Alhydrogel <sup>®</sup> (alum) treated controls showed preservation of cognition, function, and hippocampal volume, with early onset and striking effect size. Aging is the highest risk factor for developing AD. We propose repurposing Alhydrogel <sup>®</sup> , form...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
27856455-c39b-5c67-9aa1-af7d8f03483c
DOI
10.21203/rs.3.rs-9541548/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Alhydrogel TM , a widely used adjuvant, modulates multiple networks implicated in brain aging and has potential in the prevention of age-related cognitive declineDOI 10.21203/rs.3.rs-9541548/v1
Select a neighboring publication to make it the new centre.